With deeper phenotyping, we uncovered that clinically, this model exhibits features of both the less severe hepatic phenotype of GSD IV (liver fibrosis, hepatomegaly, and elevated ALT without progressive liver failure) and APBD. This evidence concerns the gene GPT and liver failure.